Loading...

Targeted and novel therapy in advanced gastric cancer

The systemic treatment options for advanced gastric cancer (GC) have evolved rapidly in recent years. We have reviewed the recent data of clinical trial incorporating targeted agents, including inhibitors of angiogenesis, human epidermal growth factor receptor 2 (HER2), mesenchymal–epithelial transi...

Full description

Saved in:
Bibliographic Details
Published in:Exp Hematol Oncol
Main Authors: Selim, Julie H., Shaheen, Shagufta, Sheu, Wei-Chun, Hsueh, Chung-Tsen
Format: Artigo
Language:Inglês
Published: BioMed Central 2019
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6788003/
https://ncbi.nlm.nih.gov/pubmed/31632839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-019-0149-6
Tags: Add Tag
No Tags, Be the first to tag this record!